跳到正文

Athira Pharma, Inc.(ATHA)内部人交易:高管与董事近期交易

过去 18 个月,共有 9 位内部人为 Athira Pharma, Inc.(ATHA)报告了 32 笔 Form 4 交易(最近一笔 2026-01-05)。

日期内部人职务类型股数市值
2026-01-05Renninger RobertChief Financial Officer买入1,000$2,310
2026-01-05Renninger RobertChief Financial Officer买入1,236$0
2026-01-05Renninger RobertChief Financial Officer卖出297$2,043
2026-01-05Worthington MarkGeneral Counsel and CCO买入3,667$0
2026-01-05Worthington MarkGeneral Counsel and CCO卖出876$6,027
2026-01-05Litton Mark JamesPresident and CEO买入10,834$0
2026-01-05Litton Mark JamesPresident and CEO卖出2,586$17,792
2026-01-05CHURCH KEVINCHIEF SCIENTIFIC OFFICER买入1,000$2,310
2026-01-05CHURCH KEVINCHIEF SCIENTIFIC OFFICER买入3,667$0
2026-01-05CHURCH KEVINCHIEF SCIENTIFIC OFFICER卖出876$6,027
2026-01-05San Martin JavierCHIEF MEDICAL OFFICER买入4,667$0
2026-01-05San Martin JavierCHIEF MEDICAL OFFICER卖出1,644$11,311
2025-12-23PERCEPTIVE ADVISORS LLC董事买入329,756$2.1M
2025-12-23PERCEPTIVE ADVISORS LLC董事买入989,270$6.3M
2025-12-23PERCEPTIVE LIFE SCIENCES MASTER FUND LTD董事买入989,270$6.3M
2025-12-23Perceptive Xontogeny Venture Fund II, LP董事买入989,270$6.3M
2025-12-23EDELMAN JOSEPH董事买入329,756$2.1M
2025-12-23EDELMAN JOSEPH董事买入989,270$6.3M
2025-12-23PERCEPTIVE LIFE SCIENCES MASTER FUND LTD董事买入329,756$2.1M
2025-12-23Perceptive Xontogeny Venture Fund II, LP董事买入329,756$2.1M
2025-07-02Renninger RobertSVP, Finance and Accounting买入10,000$2,300
2025-07-02Renninger RobertSVP, Finance and Accounting买入12,359$0
2025-07-02Renninger RobertSVP, Finance and Accounting卖出2,897$840
2025-07-02CHURCH KEVINCHIEF SCIENTIFIC OFFICER买入10,000$2,300
2025-07-02CHURCH KEVINCHIEF SCIENTIFIC OFFICER买入36,666$0

来源:SEC Form 4 申报文件 · 截至 2026-01-05